Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5582/ddt.2020.03008 http://scihub22266oqcxt.onion/10.5582/ddt.2020.03008 32336723!ä!32336723       Drug+Discov+Ther 2020 ; 14 (2): 67-72 Nephropedia Template TP {{tp|p=32336723|t=2020. Treatment of SARS-CoV-2: How far have we reached?|pdf=|usr=}}{{32336723}} gab.com Text Treatment of SARS-CoV-2: How far have we reached JO: Drug Discov Ther http://www.kidney.de/pget.php?&tw=1&pmid=32336723 #FOAvip The virus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is currently affecting more than 200 countries and territories worldwide. It has been declared as pandemic by World Health Organization (WHO) and the whole world is suffering from corona virus disease 2019 (COVID-19). Currently, no treatment for SARS-CoV-2 are approved because of lack of evidence, but a number of clinical trials are in process and we are expecting fruitful results very soon. This review focuses on various approaches of treatment and few of the most recent clinical trials carried out in this field. Twit Text FOAVip Treatment of SARS-CoV-2: How far have we reached ????Drug Discov Ther http://www.kidney.de/pget.php?&tw=1&pmid=32336723 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32336723 #FOAvip English Wikipedia <ref>{{Cite pmid|32336723}}</ref> Treatment of SARS-CoV-2: How far have we reached? #MMPMID32336723 Ahsan W; Javed S; Bratty MA; Alhazmi HA; Najmi A Drug Discov Ther 2020[May]; 14 (2): 67-72 PMID32336723show ga The virus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is currently affecting more than 200 countries and territories worldwide. It has been declared as pandemic by World Health Organization (WHO) and the whole world is suffering from corona virus disease 2019 (COVID-19). Currently, no treatment for SARS-CoV-2 are approved because of lack of evidence, but a number of clinical trials are in process and we are expecting fruitful results very soon. This review focuses on various approaches of treatment and few of the most recent clinical trials carried out in this field. |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH] |Alanine/analogs & derivatives/therapeutic use[MESH] |Amides/therapeutic use[MESH] |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19 Serotherapy[MESH] |Chloroquine/therapeutic use[MESH] |Clinical Trials as Topic[MESH] |Coronavirus Infections/drug therapy/*therapy[MESH] |Darunavir/therapeutic use[MESH] |Drug Combinations[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH] |Immunization, Passive[MESH] |Indoles/therapeutic use[MESH] |Interferon-alpha/therapeutic use[MESH] |Interferon-beta/therapeutic use[MESH] |Lopinavir/therapeutic use[MESH] |Pandemics[MESH] |Pneumonia, Viral/*therapy[MESH] |Pyrazines/therapeutic use[MESH] |Ritonavir/therapeutic use[MESH]Treatment of SARS-CoV-2: How far have we reached?(epmc).pdf DeepDyve Pubget Overpricing